Lake Street Maintains Buy on Cellebrite DI, Raises Price Target to $23
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
Lake Street analyst Eric Martinuzzi maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $22 to $23.
Lake Street analyst Eric Martinuzzi maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $22 to $23.